Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is injected once weekly into subcutaneous tissue just beneath the skin. Understanding the approved injection sites and rotation strategies helps maximize treatment consistency and minimize local tissue complications over months of therapy.
Three FDA-Approved Semaglutide Injection Sites
The abdomen, upper thigh, and outer upper arm are the three anatomically approved locations for semaglutide self-injection. Each site has distinct advantages depending on patient comfort, visibility, and injection technique. The abdomen provides the largest injection surface area and may allow easier self-administration by most patients. The thigh and upper arm offer alternative sites when abdominal tissue rotation becomes limited or when patients prefer variety in their injection routine.
Subcutaneous injection means the needle penetrates only the fatty tissue layer beneath the skin, never reaching muscle or vital organs. This shallow depth minimizes discomfort and allows consistent drug absorption across all three approved anatomical regions. Pinching the skin gently before injection can help some patients feel more secure and reduce anxiety about needle depth.
Why Rotating Injection Sites Matters for Long-Term Use
Lipohypertrophy—thickened, lumpy tissue that develops from repeated injections in the same spot—can occur with weekly semaglutide use over months or years. Site rotation prevents this complication by distributing injection trauma across multiple body locations. Patients who inject in the same small area repeatedly may experience reduced medication absorption and unpredictable weight loss results.
A practical rotation system involves selecting four to five distinct injection points within the abdomen, then moving systematically through the thigh and upper arm over successive weeks. Many patients create a written schedule or use phone reminders to track which site they used each week. This organized approach eliminates guesswork and ensures no single anatomical area receives excessive needle punctures.
Anatomical Landmarks for Safe Semaglutide Administration
The abdomen offers the widest injection zone, extending from the rib cage down to the groin area, excluding a two-inch circle around the belly button. The outer thigh—not the inner thigh—provides a secondary site that many patients find convenient for work or travel. The upper arm injection site should target the back of the upper arm between shoulder and elbow, in the fatty tissue lateral to the bone.
Patients should avoid injecting directly over bruises, scars, stretch marks, or areas of existing skin irritation. These compromised tissue zones may absorb medication inconsistently or trigger increased inflammation. A simple visual inspection before each injection takes just seconds and prevents complications that could otherwise undermine weeks of treatment progress.
PlexusDx Compounded Semaglutide: Personalized Injection Support
PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies to all 50 states without requiring insurance, starting at $149 per month. Each patient receives the same flat monthly cost regardless of dose level, because PlexusDx pricing follows the principle that your dose may increase but your price will not. This transparent, non-escalating fee structure removes barriers for patients who need dose adjustments as their body responds to treatment.
PlexusDx patients may choose the optional Precision Peptide Genetic Test for $99 after their first treatment month. This peptide-pathway genetic assessment evaluates variants in GLP1R, GIPR, FTO, and MC4R genes that influence individual response to semaglutide therapy. Understanding your genetic peptide profile helps PlexusDx tailor your treatment plan and injection schedule for maximum efficacy and safety. HSA and FSA accounts cover both medication and genetic testing costs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I switch semaglutide injection sites each week?
Yes, rotating between abdomen, thigh, and upper arm each week is strongly recommended. This practice prevents lipohypertrophy and ensures consistent medication absorption. Most patients develop a comfortable four-to-five-site rotation system within their first month of self-injection.
What happens if I inject semaglutide into muscle instead of fat?
Injecting into muscle tissue may cause increased discomfort and potentially alter medication absorption rates. Semaglutide is formulated for subcutaneous injection into fatty tissue beneath the skin. Using the pinch-and-inject technique or allowing a trained clinician to demonstrate proper needle angle helps ensure accurate subcutaneous delivery.
How much does PlexusDx compounded semaglutide cost monthly?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required and no membership fees. Your monthly cost remains flat even if your dose increases—pricing never changes with dose adjustments. HSA and FSA accounts are eligible for both medication and optional genetic testing expenses.
Is lipohypertrophy reversible if I've been injecting the same spot?
Lipohypertrophy can gradually resolve over several months once you discontinue injections in that location and rotate to fresh sites. The thickened tissue typically softens and flattens with time, though complete reversal may take extended periods. Beginning site rotation immediately upon starting semaglutide prevents this complication entirely.
How does genetic testing help optimize my semaglutide injection plan?
PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict your individual semaglutide response. Patients with certain genetic profiles may benefit from specific dose timing or combination protocols. This $99 add-on test after your first month helps clinicians personalize your injection schedule for faster, safer results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Wegovy and Naltrexone Together for Weight Loss?
Navigating Weight Loss: Can You Take Wegovy and Phentermine for Optimal Results?